Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries
Autor: | Rupert Bauersachs, PD Gumbs, Giancarlo Agnelli, Ling-Hsiang Chuang, Alexander T. Cohen, David Jiménez, Anselm K. Gitt, Patrick Mismetti, Ben van Hout, S Kroep, Stephen N Willich, Manuel Monreal |
---|---|
Rok vydání: | 2019 |
Předmět: |
Male
medicine.medical_specialty Health-related quality of life Health Status Pain Anxiety Article 03 medical and health sciences 0302 clinical medicine Disease registry Cost of Illness Quality of life Recurrence Neoplasms Internal medicine Humans Medicine Prospective Studies Registries Burden of illness Mortality Prospective cohort study Stroke Aged Depression business.industry 030503 health policy & services Mortality rate Public Health Environmental and Occupational Health Cancer Middle Aged medicine.disease Pulmonary embolism Europe Venous thromboembolism Female Pulmonary Embolism Quality of Life 030220 oncology & carcinogenesis Observational study 0305 other medical science business |
Zdroj: | Quality of Life Research |
ISSN: | 1573-2649 0962-9343 |
Popis: | Purpose Little is known about the quality of life following pulmonary embolism (PE). The aim of the study was to assess the 12-month illness burden in terms of health-related quality of life (HrQoL) and mortality, in relation to differences in patient characteristics. Methods The PREFER in VTE registry, a prospective, observational study conducted in seven European countries, was used. Within 2 weeks following an acute symptomatic PE, patients were recruited and followed up for 12 months. Associations between patient characteristics and HrQoL (EQ-5D-5L) and mortality were examined using a regression approach. Results Among 1399 PE patients, the EQ-5D-5L index score at baseline was 0.712 (SD 0.265), which among survivors gradually improved to 0.835 (0.212) at 12 months. For those patients with and without active cancer, the average index score at baseline was 0.658 (0.275) and 0.717 (0.264), respectively. Age and previous stroke were significant factors for predicting index scores in those with/without active cancer. Bleeding events but not recurrences had a noticeable impact on the HrQoL of patients without active cancer. The 12-month mortality rate post-acute period was 8.1%, ranging from 1.4% in Germany, Switzerland, and Austria to 16.8% in Italy. Mortality differed between patients with active cancer and those without (42.7% vs. 4.7%). Conclusion PE is associated with a substantial decrease in HrQoL at baseline which normalizes following treatment. PE is associated with a high mortality rate especially in patients with cancer, with significant country variation. Bleeding events, in particular, impact the burden of PE. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |